Cancer
Clinical Trials: Overview
Treatment Resistent Cancers
Cancer Therapies
Cancer Therapies
Preclinical Development: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 29, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
1National Cancer Institute, Bethesda, MD, USA. yanceym@mail.nih.gov
No abstract available in PubMed .
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016